Logo better3

53 W. Jackson Blvd., Suite 1320
Chicago, IL 60604

In re Suboxone (Buprenorphine Hydrochloride and Naloxone) Antitrust Litig., MDL No. 2445 (E.D. Pa.)

Miller Law is pleased to announce that the District Court presiding over this matter has preliminarily approved the class action settlement between the end-payor plaintiff class and defendant Indivior f/k/a Reckitt Benckiser Pharmaceuticals.   Under the terms of the settlement, and among other things, Indivior has agreed to pay the class $30,000,000.00.  A copy of the preliminary approval order can be found here